Dr. Jobe, director of the Esophageal and Lung Institute, is a nationally renowned pioneer in the field of minimally invasive surgery and endoscopic therapy for the treatment of esophageal cancer, Barrett’s esophagus, esophageal mobility disorders and gastroesophageal reflux disease (GERD). A prolific medical researcher and international lecturer, Dr. Jobe serves as the principal investigator for two NIH grants that focus on improving early detection of esophageal cancer, specifically on the development of serum and tissue biomarkers, a precursor to a blood test for the early detection and treatment of esophageal cancer. In 2015, Dr. Jobe received Pittsburgh Business Times’ Health Care Heroes award in the Health Care Innovation – Individual category for his discovery of four protein biomarkers which resulted in highly accurate and inexpensive findings in determining whether or not cancer was present.